← Open Payments lookup

HOLLY LOFTON: Open Payments

NPI 1104010511 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$171,327 in 198 payments from 10 companies in 2025. Trend: 2023 $60,258 · 2024 $183,965 · 2025 $171,327

Speaker / faculty: $117,929Consulting: $37,891Travel & lodging: $10,555Food & beverage: $4,953
CompanyPaymentsAmount
Lilly USA, LLC96$92,509
Novo Nordisk Inc68$63,289
Eli Lilly and Company8$5,500
Currax Pharmaceuticals LLC9$5,482
ABBVIE INC.1$2,250
Madrigal Pharmaceuticals5$1,885
Boehringer Ingelheim Pharmaceuticals, Inc.6$180
Intra-Sana Laboratories1$114
Corcept Therapeutics3$65
Perspectum Diagnostics Ltd1$53

Products named: ZEPBOUND, Wegovy, Saxenda, CONTRAVE, IMBRUVICA, REZDIFFRA, MOUNJARO, JARDIANCE.

Industry payments across NY — which companies pay providers there.